Subsequent analyses revealed a significantly higher number of tumor-infiltrating CD8+ T cells, an increased expression of PD-L1 tumor cells, a higher rate of T cell clonality, and higher levels of lymphoid markers in responding patients compared to non-responders [43]. This evidence concerns the gene CD8A and neoplasm.